jueves, 2 de julio de 2020

Health experts slam US mass purchase of licensed Covid-19 drug remdesivir | coronavirus outbreak News,The Indian Express

Health experts slam US mass purchase of licensed Covid-19 drug remdesivir | coronavirus outbreak News,The Indian Express

remdesremdesivir covid treatment, remdesivir US stock, health experts criticizes US, remdesivir supply, remdesivir shortage, worl dnews, US coronvairusivir covid treatment, remdesivir india covid treatment, remdesivir supply, remdesivir shortage,

Health experts slam US mass purchase of licensed Covid-19 drug remdesivir



The Department of Health and Human Services said it had secured 500,000 treatments of the drug through September, representing 100% of Gilead’s July production capacity and 90% of its capacity in August and September.

No hay comentarios:

Publicar un comentario